Day 2-psychopharmacotheapy Flashcards

(152 cards)

1
Q

psychopharmacotherapy

A

a subspeciality of pharmacology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

classes of psychopharm

A

antipsychotics
mood stabilizers
antidepressants
antianxiety
stimulants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

pharmacodynamics

A

where drugs act
what does the drug do to the body
how intense of an effect does it have
where does it have that effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

4 sites of drug action

A

receptors
ion channels
enzymes
carrier proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

receptors

A

all drugs mimic some biological action that we naturally have

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

agonist

A

working with or add to the natural process

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

antagonist

A

working against the natural biologic process

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

selectivity

A

specific for a receptor
lock and key

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

affinity

A

degree of attraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

intrinsic activity

A

ability to produce a biologic response once it is attached to receptor
will it actually do waht we want and produce a therapeutic effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ion channels

A

drugs can block or open then

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

example of ion channels

A

benzodiazepine drug facilitate GABA neurotransmitter in opening the chloride ion channel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

enzymes

A

complex proteins that catalyze specific biochemical reactions within cells and are targets for some drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

enzyme example

A

monoamine oxidase is an enzyme that breaks down most bioamine neurotransmitters
MAOIs inhibit the breakdown of bioamine neurotransmitters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

bioamine neurotransmitters

A

NE, DA serotonin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

too much NE

A

anxiety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

too much DA

A

psychosis or depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

too much MAO

A

they break down serotonin causing depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

prescribing medication

A

we don’t know what causes mental health symptom so we try all classes until one works

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

carrier proteins

A

function is to take neurotransmitter back into presynaptic cell after neurotransmitter have activated receptors in the synapse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

example of carrier protein

A

SSRI mostly used for anxiety, depression, schizophrenia and PTSD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

efficacy

A

ability to produce desired response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

potency

A

dose required to produce desired response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

ss of effect due to biologic adaptation

A

tolerance
treatment refractory
side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
tolerance
your body getting used to having them and this becomes its baseline
26
treatment refractory
drug resistant from the start so they don't respond to anything
27
side effects
all meds have them because we have receptors distributed in all parts of the body but we only want to target the brain
28
drug toxicity
concentation of the drug in the body greater than the safe range and may become harmful or poisonous to the body
29
therapeutic index
ratio between minimum effective dose and maximum safe dose the higher the ratio the better because more space between high and low
30
pharmacokinetics
what does the body do to a drug ADME
31
absorption
movement from the site of administration to the plasma
32
ways to administer psychotropic medications
oral IM IV
33
IM injections
short or long acting good for non compliance no pocketing convinient
34
first pass metabolism
before reaching the circulation higher first pass lower response
35
bioavailability
how much reached the circulation unchanged
36
distribution
reflects how easy it is for a drug to pass out of teh systemic circulation and move into other types of tissues
37
solubility of drugs
most are water soluble and don't go to the brain psychiatric drugs must cross BBB and are therefore fat soluble
38
factors effecting distribution
amount of blood flow or perfusion within the tissue how lipophilic the drug is anatomic barriers like the BBB the drug must cross
39
metabolism
process by which the drug is altered and broken down into smaller substances (metabolites ) that are usually inactive commonly carried out in the liver
40
lipid soluble and metabolism
usually become more water soluble and are therefore excreted
41
excretion
the elimination from the body eitehr unchanged or as metabolites
42
half life
the time required for plasma concentrations of the drug to be reduced by 50% dosing frequency based on this
43
dosing
administration of medication over time so that therapeutic levels can be achieved
44
steady state
drug accumulates and plateuas at a particular level rate of accumulation is determined by half life
45
reaching steady state
when the rate of drug input is equal to the rate of drug elimination maintenace dosing 5x the elimination half life for a drug after regular dosing started
46
plateaus
any increase in dose doesn't improve condition
47
titration
slowly working up to an effective dose done because of severe side effects, allergy risk or narrow therapeutic indexi
48
individual variations of drug effects age
alteration in gastric absorption renal function is altered in very young and old liver metabolism decreases with age
49
ethnicity and genetic make up variability
genetics play a significant role in the metabolism of medication
50
phases of drug treatment
initiation stabilization maintenance discontiuation
51
stabilization
from the start until you achieve a stable level that is working
52
discontinuation
not common in mental health
53
antipsychotic medication target symptoms
psychotic symptoms positive and negative
54
types of antipsychotics
first generation/typical second generation/atypical. Good for positive and negative
55
preparations of antipsychotics
Oral IM depot-haloperidol and fluphenazine long acting injectable-risperdal constants
56
side effects antipsychotics
orthostatic hypotension anticholinergic metabolic syndrome/weight gain endocrine and sexual drive decreased blood dysstasias agranulocytosis (clozapine) EPS NMS
57
acute agitation
5mg haloperidol and 5mg benzodiazepine
58
poor response to antipsychotic medication
obtaining antipsychotic plasma levels in patients who hhave had poor response despite a trial with an adequate dose/duration of medication can be helpful to rule out adherence, idenntify rapid elimination, confirm true treatment resistance
59
rapid elimination
their half life is much shorter than normal resulting in low blood levels
60
typical antipsychotics
phenothiazines haloperidol (haldol)h
61
Haldol use
acute agitation
62
atypical antipsychoticw
clozapine risperidone olanzapine quetiapine ziprasidone aripiprazole
63
clozapine
Clozaril last resort due to agranulocytosis
64
Risperidone
Risperdal common, most potent
65
olanzapine
Zyprexa common at 5-10mg/day
66
quetiapine
seroquel bad at antipsychotic but stabilizes, mood, anxiety, depression and a sleeping aid
67
medication related movement disorder
cased by blocking dopamine receptors 3 or more anti psychotics lead to high risk
68
acute EPS
dystonia Parkinsonism akathiasia
69
dystonia
involuntary muscle spasms, abnormal postures
70
parkinsonism
rigidity, akinesia, tremor, mask like face, loss of spontaneous movement
71
akathisia
inability to sit still, restlessness
72
akinesia
slow movement
73
treatment of EPS
anticholinergic medication for hystonia, parkinsonism akathisia does not ususally repond to meds but beta blocker are the best option
74
Cogentin
often in an injection of haloperidol and ativan in prediction of EPS symptoms
75
chronic movement disorder
tardive dyskinesia treatment is irreversible
76
tardive dyskinesia symptoms
irregular, repetitive involuntary movements of the mouth, face and tonge, including chewing, tongue protrusion, lip smacking, puckering of the lips and rapid eye blinking abnormal finger movements are common
77
prevention of EPS
using lowest dose possible
78
prevention of tardive dyskinesia
using lowest possible dosage minimizing use of PRN antipsychotic medication closely monitoring individuals in high risk gropus
79
high risk groups for tardive dyskinesia
late teens and early twenties
80
mood stabilizers
used primarily for stabilizing mood treating BPD I and II
81
first line of BPD
lithium carbonate and divalproex sodium/valproic acid
82
BPD I
patients have mania and depression mania putting people out of life
83
BPD II
patient has depression and hypomania less severe usually a person can function in life
84
lithium carbonate
action unknown but effective for BPD
85
side effects of carbonate
thrist metallic taste increased frequency of urination fine head and hand tremor drowsiness and mild diarrhea
86
adverse effects of lithium
toxicity so measure blood levels monitor salt intake and dehydration because as salt increases lithium decrease monitor creatinine concentration monitor thyroid hormones every 6 months avoid in pregnancy monitor CBC q6month
87
mood stabilizers anticonvulsants
valproates and derivates carbamazepine gapapentin lamotrigine tropiramate
88
valproates and derivates
divalproex sodium
89
carbamazepine
tegretol only if not responding to others
90
gabapentin
neurotensin olanzapine antipsychotic is more common than it is for BPD
91
Lamotrigine
Lamictal BPD II not strong enough of BPD I
92
topiramate
Topamax rarely seen for BPD
93
mechanism of BPD
cause an increase GABA neurotransmitter in brain
94
kindling of BPD
a commonly used model for the development of seizures and epilepsy in which the duration and behavioral involvemetn of induced seizures increases after seizures are induced repeatedly in the context of manic episodes too
95
kindling common words
every manic episode lowers the threshold for the next one
96
anticonvulsant side effects
dizziness, drowsiness, tremor, visual disturbances, nausea and vomiting weight gail (all psych med) alopecia
97
interventions for BPD
minimized by treating in low doses given with foodi
98
depressant classes
SSRI SSNRI SNRI (anxiety because NE is related to emotion) TCA MAOIs
99
anxiety and depression
have a 50% comorbidity
100
SSRI examples
fluoxetine sertraline paroxetine fluvoxamine citalopram escitalopram take 6 weeks to reach therapeutic levels
101
Citalopram
Celexia takes 4 weeks to reach therapeutic levels but is very expensive
102
SSNRI
venlafaxine Desvenlafaxine Buloxetinev
103
venlafaxine
Effexor also treats panic disorder and social anxiety disorder
104
Desvenlafaxine
Pristiq also treats anxiety and panic disorder expensive
105
duloxetine
Cymbalta also treats anxiety and certain types of chronic pain
106
SSRI/SSNRI side effects
headache anxeity transiety nausea vomting diarrhea weight gain sexual dysfunction serononin syndrome sedation at high doses
107
serotonin syndrome
agitation confusion rapid heart rate dilated pupils muscle rigidity high fever seizures
108
when to administer SSRI
morning
109
TCA examples
amitripyline nortriptyline clomipramine doxepin trimipramine
110
TCAs
not very common only when patiens are unresponsive to SSRI, SSNRI narrow therpeutic index puts a person at higher risk of suicidal ideation
111
TCA common side effects
sedation orthostatic hypotension anticholinergic
112
other side effects of TCA
tremor restlessness insomnia confusion pedal edema headache seizures blood dyscrasias sexual dysfunction cardiotoxicity
113
MAOIs action
inhibit the enzyme that is responsbile from the metabolism of serotonin, D and NE and tyramine causes increased levels of NE and serotonin in the CNS
114
food and MAOIs
need a low tyramine diet and avoid high tyramine foods such as aged cheese, sausage causes a serious spike in BP and requires emergent treatment
115
side effects of MAOIs
dry mouth, nausea, constipation, drowsiness and light headedness drug to drug interaction
116
other antidepressants
mirtaapine trazodone nefazodone buprorion
117
Mirtazapine and Trazodone
Pereron off label use for sedation and sleeping aid
118
Bupropion
smoking cessation Wellbutrin
119
anxiety anxiety and sedative hypnotic medication
benzodiazepines and non benzodiazepines
120
Benzos
diazepam lorazepam alprazolam clonazepam
121
Diazepam
valium alcohol withdrawals because fast acting LTC drug of choice
122
Lorazepam
Ativan agitation, aggression and anxiety
123
clonazepam
Klonopin most common less rebounding syndrome or rush
124
non benzos
buspirone zopiclone
125
Rush
going from very anxious to very calm a feeling that can lead to addiction
126
benzodiazepines MOA
enhance the effects of GABA by increasing the frequency of the chloride ion channel opening thereby increasing the inhibitory effect of the neurotransmitter GABA on neuronal activity
127
effects of benzos
pronounced in the limbic system, thalamus, hypothalamus
128
side effects of benzos
sedation and CNS depression cognitive impairment developing tolerance and dependency withdrawal symptoms alcohol potentiates CNS depression avoid in the elderly
129
use of benzos
short term
130
stimulants
amphetamines used in treating narcolepsy, ADHD and obesity exact MOA unknown
131
amphetamines example
destroamphetamine methylphenidate pemoline
132
dextroamphetamine
Dexedrine half life 6-7 hours
133
methylphenidate
Ritalin half life 2-4 hours
134
Pemoline
Cylert half life 12 hours
135
stimulants off label use
adjunction iwth other depressants to treat depression and also relieve lethary and reduce cognitive deficits
136
side effects of stimulants
insomnia, nervousness, restlessness, tachycardia, heart problems, risk for growth suppression
137
medication non adherence patient teaching
identify reason importance of medication regimen if its due to side effects review dose or change medication class
138
importance of medication adherence
attitude towards medication insight side effects
139
managing non responders
optimize dose and ensure adequate trial switching meds augmentation combination atypical antipsychotics ETC
140
switching
antidepressant within same class or other class
141
augmentation
adding non antidepressant medication
142
combination
using 2 or more antidepressants
143
ECT
imitate generalized seizure by an electrical current short acting anesthetic and muscle relaxant given repeat procedure 2-3x per week mechanism unknown
144
use of ECT
rapid relief of depressive symptoms
145
side effects of ECT
memory loss (short and long term) hypo or hypertension bradycardia or tachycardia and minor arrhythmias immediately after
146
effectiveness of ECT
80% SSRI 40-50%
147
new somatic therapies
repetitive transcranial magnetic stimulation and vagus nerve stimulation
148
vagus nerve stimulation
involves a device to stimulate the Vagus nerve with electrical impulses an implantable option to treat epilepsy and depression
149
light therapy/photo therapy
resets circadian rhythm used for seasonal affective disorder
150
nutritional therapies
neurotransmitter necessary for normal, healthy functioning of the brain nutrients produced fromamino acids taken from food
151
ketamine treatment
very effective for depression and suicidal behaviors but not covered by health care
152